Epstein Secrets

cal need to reduce the 45% failure rate of coronary artery by-pass grafts. This is a major unmet medical need in both Russia and the United States. Russian Venture Capital has agreed to provide approximately half of the capital ($3.0M) to launch MALI in its Series A Round. I need to find the matching approximate $3.5M.

civic minded interest". (The Russians Love OvationBio, but we need to show them "proof of concept", before they can/will invest.) ConcentRx: I like ConcentRx. It is personalized cancer therapy. We will only beat cancer when we learn to treat it individually, and one patient at a time. I am pretty sue I h

cal need to reduce the 45% failure rate of coronary artery by-pass grafts. This is a major unmet medical need in both Russia and the United States. Russian Venture Capital has agreed to provide approximately half of the capital ($3.0M) to launch MAJI in its Series A Round. I need to find the matching approximate $3.5M.

civic minded interest". (The Russians Love OvationBio, but we need to show them "proof of concept", before they can/will invest.) ConcentRx: I like ConcentRx. It is personalized cancer therapy. We will only beat cancer when we learn to treat it individually, and one patient at a time. I am pretty sue I h

cal need to reduce the 45% failure rate of coronary artery by-pass grafts. This is a major unmet medical need in both Russia and the United States. Russian Venture Capital has agreed to provide approximately half of the capital ($3.0M) to launch MAJI in its Series A Round. I need to find the matching approximate $3.5M.

civic minded interest". (The Russians Love OvationBio, but we need to show them "proof of concept", before they can/will invest.) ConcentRx: I like ConcentRx. It is personalized cancer therapy. We will only beat cancer when we learn to treat it individually, and one patient at a time. I am pretty sue I h